RAPTIVA NEWS HIGHLIGHTS
Media Articles Related to Raptiva (Efalizumab)
After Fits and Starts, New Hope for Psoriasis Patients (HealthDay)
Source: Y! Health News Search RSS Feed [2008.08.25]
Xamiol(R) - LEO Pharma's New Drug For The Treatment Of Scalp Psoriasis - Is Approved In Europe
Source: Dermatology News From Medical News Today [2008.08.24]
Psoriasis: More Than Skin Deep
Source: Dermatology News From Medical News Today [2008.08.22]
Possible New Treatment For Psoriasis
Source: Dermatology News From Medical News Today [2008.08.08]
Psoriasis
Source: MedicineNet Anal Itching Specialty [2008.06.24]
Published Studies Related to Raptiva (Efalizumab)
Subcutaneous efalizumab is not effective in the treatment of alopecia areata. [2008.03]
Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis: An Open-Label Extension of a Phase IIIb Trial. [2008]
Efalizumab for the treatment of psoriatic arthritis. [2007.03]
CLinical experience acquired with the efalizumab (Raptiva) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial. [2006.07]
Safety of efalizumab in adults with chronic moderate to severe plaque psoriasis: a phase IIIb, randomized, controlled trial. [2006.05]
Clinical Trials Related to Raptiva (Efalizumab)
Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy [Active, not recruiting]
Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva [Terminated]
A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g [Completed]
Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes [Recruiting]
A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis [Completed]
|
